Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee.
D000260:Adenoviruses, Human / Q000235:genetics*; D026683:Advisory Committees; D002986:Clinical Trials as Topic / Q000009:adverse effects / Q000592:standards*; D004274:DNA, Recombinant / Q000627:therapeutic use*; D017809:Fatal Outcome; D018014:Gene Transfer Techniques / Q000009:adverse effects*; D015316:Genetic Therapy / Q000009:adverse effects* / Q000592:standards*; D005822:Genetic Vectors; D006801:Humans; D007258:Informed Consent; D009316:National Institutes of Health (U.S.); D035842:Research Subjects; D012449:Safety; D014481:United States
D004274:DNA, Recombinant